Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene

被引:2
|
作者
Na, Do Hyun [1 ,2 ,3 ,7 ]
Lim, Sun Woo [1 ,2 ]
Kim, Bo-Mi [1 ,2 ]
Kim, Kyoung Woon [1 ,2 ]
Shin, Yoo Jin [1 ,2 ]
Chae, Hyojin [4 ,5 ,6 ]
Ko, Eun Jeong [1 ,2 ,3 ]
Yang, Chul Woo [1 ,2 ,3 ]
Kim, Myungshin [4 ,5 ,6 ]
Ha Chung, Byung [1 ,2 ,3 ]
机构
[1] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul St Marys Hosp, Seoul, South Korea
[5] Catholic Univ Korea, Coll Med, Catholic Genet Lab Ctr, Seoul St Marys Hosp, Seoul, South Korea
[6] Catholic Univ Korea, Coll Med, Ctr Appl Genom & Precis Med, Seoul St Marys Hosp, Seoul, South Korea
[7] Republ Korea Air Force, Korea Ordnance Tact Attack Range, Gangwon, South Korea
基金
新加坡国家研究基金会;
关键词
Karyomegalic interstitial nephritis; FAN1; gene; Induced pluripotent stem cell;
D O I
10.1016/j.scr.2020.101876
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The human-induced pluripotent stem cell (KIN-hiPSCs) line (CMCi001-A), derived from peripheral blood mononuclear cells (PBMCs) of a 42-year-old woman with karyomegalic interstitial nephritis (KIN) caused by the mutation of FANCD2/FANCI-Associated Nuclease 1 (FAN1) gene, was generated using Sendai virus. KIN-hiPSCs showed a typical human embryonic stem cell like morphology and expressed all pluripotency-associated markers, and directly differentiated into all three germ layers. Karyotyping of PBMCs of the patient and KIN-hiPSCs showed 47, XXX. In summary, we generated a novel patient-specific hiPSC line containing the mutation of FAN1 gene and it can be used to provide additional insights for KIN pathophysiology.
引用
收藏
页数:4
相关论文
共 30 条
  • [21] Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation
    Meraviglia, Viviana
    Ganesh, Sravya
    Arendzen, Christiaan H.
    Freund, Christian
    Sommariva, Elena
    Rossini, Alessandra
    Bellin, Milena
    STEM CELL RESEARCH, 2021, 54
  • [22] Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene
    Ababneh, Nidaa A.
    Ali, Dema
    Barham, Raghda
    Al-Kurdi, Ban
    Sharar, Nour
    Al Hadidi, Sabal
    Qanno', Omar
    Ryalat, Abdee T.
    Salah, Bareqa
    Awidi, Abdalla
    STEM CELL RESEARCH, 2020, 48
  • [23] Generation of a human induced pluripotent stem cell line NTUHi004-A from a patient with Leigh syndrome harboring a homozygous missense mutation c.836 T > G (p.Met279Arg) in NDUFAF5 gene
    Ou-Yang, Chih-Hsin
    Chen, Pin-Shiuan
    Lin, Chin-Hsien
    STEM CELL RESEARCH, 2024, 76
  • [24] RETRACTION: Establishment of a human induced pluripotent stem cell line, KMUGMCi001-A, from a patient bearing a heterozygous c.772+3_772+4dup mutation in the ACVRL1 gene leading Telangiectasia, hereditary hemorrhagic, type 2 (HHT2)
    Ura, Hiroki
    Togi, Sumihito
    Iwata, Yumiko
    Ozaki, Mamoru
    Niida, Yo
    STEM CELL RESEARCH, 2022, 61
  • [25] An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182 T>C ) mutation in the NPC1 gene
    Li, Rong
    Pradhan, Manisha
    Xu, Miao
    Roeder, Amanda
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Porter, Forbes D.
    Zhen, Wei
    STEM CELL RESEARCH, 2020, 44
  • [26] Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene
    Xiao, Cheng
    Yu, Miao
    Liu, Jieying
    Wu, Han
    Deng, Mingqun
    Zhang, Qian
    Xiao, Xinhua
    STEM CELL RESEARCH, 2020, 42
  • [27] Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2
    Gao, Xue
    Qiu, Shi-Wei
    Feng, Meng-Long
    Huang, Sha-Sha
    Kang, Dong-Yang
    Han, Ming-Yu
    Dai, Pu
    Yuan, Yong-Yi
    STEM CELL RESEARCH, 2020, 48
  • [28] Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene
    Hoepperger, Sabrina
    Spathopoulou, Angeliki
    Mayer-Suess, Lukas
    Suarez-Cubero, Marta
    Sillaber, Katharina
    Spreiz, Ana
    Kiechl, Stefan
    Edenhofer, Frank
    Fellner, Lisa
    STEM CELL RESEARCH, 2024, 75
  • [29] Generation and characterization of human induced pluripotent stem cell line METUi002-A from a patient with primary familial brain calcification (PFBC) carrying a heterozygous mutation (c.687dupT (p. Val230CysfsTer28)) in the SLC20A2 gene
    Begentas, Onur Can
    Koc, Dilara
    Sendur, Nuriye Kayali
    Besarat, Peri
    Ezgin, Sena
    Temel, Musa
    Bora, Hatice Ayse Tokcaer
    Kiris, Erkan
    STEM CELL RESEARCH, 2023, 72
  • [30] Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi018-A) from a patient with Charcot-Marie-Tooth disease type 2EE (CMT2EE) due to a homozygous c.122G > A p.(Arg41Gln) mutation in the MPV17 gene
    Ababneh, Nidaa A.
    Barham, Raghda
    Al-Kurdi, Ban
    Al Hadidi, Sabal
    Ali, Dema
    Abdulelah, Ahmed A.
    Madadha, Adan
    Masri, Amira
    Awidi, Abdalla
    STEM CELL RESEARCH, 2024, 81